Xiaojun Zhou
Position not listed
Renmin University of China · Beijing
Source
OpenAlexVerification
Academic database source — not independently verified
On file
- Not publicly verified
- ORCID
- 0000-0001-5040-8053
- Lab or group
- Not publicly verified
- Supervision
- Not publicly verified
- Last updated
- 2026-10-05
Research areas
Research interests
Bone Tissue Engineering Materials, Renal cell carcinoma treatment, Electrospun Nanofibers in Biomedical Applications, 3D Printing in Biomedical Research, Nanoplatforms for cancer theranostics
Funding
Unknown
Not publicly verified. No grant, project, or funded-student record is stored.
Research timeline
Newest stored year: 2025. Topics on file: Bone Tissue Engineering Materials, Renal cell carcinoma treatment, Electrospun Nanofibers in Biomedical Applications, 3D Printing in Biomedical Research, Nanoplatforms for cancer theranostics.
2025
- 3D printed shape-memory piezoelectric scaffolds with in-situ self-power properties for bone defect repair (2025)
- A Double-Reactive Biodegradable Elastomer Enables Functional Modification of Fibrous Grafts for More Positive Regeneration of Arterial Tissues (2025)
- NIR-Activatable Antibacterial 3D-Printed Hydrogel Scaffold with Controllable Drug Release for Enhanced Vascularized Bone Regeneration (2025)
- Sprayable Ionic Tattoo Exploiting Biocompatible and Recyclable Organogel for AI‐Assisted Multisignal Sensing (2025)
- Study of genetic polymorphisms and steady-state trough concentrations of imatinib and its active metabolite in predicting efficacy in gastrointestinal stromal tumors (2025)
Papers linked only by a name match stay hidden.
Research match score
Sign in to see your personalized research match.
Target: Low priority
- Research fit is not included until you sign in and save research interests.
- Affiliation is not verified.
- No email is stored.
- A stored publication year is 2025.
- Funding evidence is unknown, so it does not raise the priority.
Match, then draft, then copy. Mark Contacted on the tracker. Follow up only after you send it yourself.
Sign in